FDA Notification - Products using oils, glycerin, or protein that were derived from the Jatropha plant may have toxic effects

The U.S. Food and Drug Administration (FDA) is notifying the regulated community that oils, glycerin, and proteins commonly used in the production of human and animal food, medical products, cosmetics, and other FDA-regulated products may contain toxins if they are derived from the Jatropha plant.

Find Out More

• FDA Office of Regulatory Affairs "Notification to Industry," titled "Products using oils, glycerin, or protein that were derived from the Jatropha plant may have toxic effects" (.pdf) 

• FDA is seeking validated testing methodologies for the detection of Jatropha-based toxins - If Jatropha-based toxins are suspected in an FDA regulated product, FDA requests that the methodology and information about the contamination be sent by e-mail to: IntentionalAdulteration@FDA.HHS.gov